Variopartner SICAV - MIV Global Medtech Fund N3

Reference Data

ISIN LU1050446076
Valor Number 24064488
Bloomberg Global ID VARMVN3 LX
Fund Name Variopartner SICAV - MIV Global Medtech Fund N3
Fund Provider MIV Global Medtech Fund Feldeggstrasse 55
8008 Zürich
Schweiz
Phone: +41 44 253 64 11
E-Mail: info@mivam.ch
Fund Provider MIV Global Medtech Fund
Representative in Switzerland Vontobel Fonds Services AG
Zürich
Phone: +41 58 283 74 77
Distributor(s) Vontobel Fonds Services AG
Zürich
Phone: +41 58 283 74 77
Asset Class Equities
EFC Category Equity Health Care
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel)
Investment Strategy *** This Sub-Fund aims to achieve maximum capital growth by means of investments in the sector of medical technology worldwide. In order to achieve this, and taking account of the principle of risk diversification, a minimum of two-thirds of the SubFund’s total assets are invested directly in equities, equity-like transferable securities, participation certificates, depositary receipts, such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs) referring to such securities, etc. from issuers worldwide, mainly active in the sector of medical technology. Besides this, up to one third of the total assets of the Sub-Fund may be invested in participation securities from companies that are not or not principally active in the sector of medical technology.
Peculiarities

Fund Prices

Current Price * 2,945.28 USD 24.12.2024
Previous Price * 2,926.71 USD 23.12.2024
52 Week High * 3,047.39 USD 18.10.2024
52 Week Low * 2,634.66 USD 03.01.2024
NAV * 2,945.28 USD 24.12.2024
Issue Price * 2,945.28 USD 24.12.2024
Redemption Price * 2,945.28 USD 24.12.2024
Closing Price *
Indicative Minimum Price
Fund Assets *** 2,251,910,748
Unit/Share Assets *** 97,660,133
Trading Information SIX

Performance

YTD Performance +9.02% 29.12.2023
24.12.2024
YTD Performance (in CHF) +16.70% 29.12.2023
24.12.2024
1 month -2.16% 25.11.2024
24.12.2024
3 months -1.53% 24.09.2024
24.12.2024
6 months +4.37% 24.06.2024
24.12.2024
1 year +9.23% 27.12.2023
24.12.2024
2 years +21.53% 27.12.2022
24.12.2024
3 years -11.45% 24.12.2021
24.12.2024
5 years +19.58% 24.12.2019
24.12.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Abbott Laboratories 10.00%
Stryker Corp 9.91%
Boston Scientific Corp 9.87%
Intuitive Surgical Inc 9.80%
Medtronic PLC 4.73%
Essilorluxottica 4.32%
Alcon Inc 4.21%
Edwards Lifesciences Corp 3.85%
Becton Dickinson & Co 3.84%
Hoya Corp 3.76%
Last data update 30.11.2024

Cost / Risk

TER 1.17%
TER date 28.06.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.10%
Ongoing Charges *** 1.17%
SRRI ***
SRRI date *** 30.11.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)